الولايات المتحدة · منصات وبيانات · The Motley Fool

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

نشره The Motley Fool · الولايات المتحدة منذ 1 س

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

اقرأ المقال كاملًا على The Motley Fool سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.fool.com)

يستحق القراءة أيضًا

MarketWatch

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

MarketBeat

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shares to Pay Dividend of $0.03

Seeking Alpha

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

مشاركة

يستحق القراءة أيضًا

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shares to Pay Dividend of $0.03

Couche-Tard makes bid for Cumberland Farms: report

Albanian police fire tear gas as anti-government student protests turn violent

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem